Physician

Adam Ching Tanaka, MD, MPH, MS

According to 2025 Medicare claims, Adam Tanaka, MD, MPH, MS (NPI: 1902434244) practices ophthalmology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is JULES STEIN EYE INSTITUTE MEDICAL GROUP (NPI: 1326006966; TIN: 954379486) and primary practice location at 91103-3534.

Tanaka's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 69 traditional Medicare patients, billed 104 HCPCS/CPT codes, and received $8,326 in Medicare payments. The top billing code was 92012 (Established patient problem focused exam of visual system). Part D data shows 161 prescription claims across 62 beneficiaries totaling $10,382 in drug costs, led by Latanoprost (Latanoprost). Open Payments data shows 15 records totaling $774. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $100 to $10,382. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$4.2K$8.3K2024 Medicare payment: $8,326 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202469104$8,326

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$5.2K$10K2020 Drug cost: $100 (USD; Tot_Drug_Cst)2021 Drug cost: $6,129 (USD; Tot_Drug_Cst)2022 Drug cost: $7,085 (USD; Tot_Drug_Cst)2023 Drug cost: $6,828 (USD; Tot_Drug_Cst)2024 Drug cost: $10,382 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R13$100
20213672$6,129
20223991$7,085
202341158$6,828
202462161$10,382

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92012Established patient problem focused exam of visual system5461$79

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LatanoprostLatanoprost632,943$783
Prednisolone AcetatePrednisolone Acetate13510$536
Brimonidine TartrateBrimonidine Tartrate13867$274
Timolol MaleateTimolol Maleate231,430$162

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.15$774ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Ching Tanaka, MD, MPH, MS?

Tedicare shows public-source Medicare data for Adam Ching Tanaka, MD, MPH, MS (NPI 1902434244), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Ching Tanaka, MD, MPH, MS have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Ching Tanaka, MD, MPH, MS?

Adam Ching Tanaka, MD, MPH, MS is linked to JULES STEIN EYE INSTITUTE MEDICAL GROUP (billing NPI 1326006966) in the available physician profile data.

Does Adam Ching Tanaka, MD, MPH, MS have Open Payments data?

Adam Ching Tanaka, MD, MPH, MS has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.